221 related articles for article (PubMed ID: 36046045)
1. The immune-related role of beta-2-microglobulin in melanoma.
Wang C; Wang Z; Yao T; Zhou J; Wang Z
Front Oncol; 2022; 12():944722. PubMed ID: 36046045
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of
Wang MM; Koskela SA; Mehmood A; Langguth M; Maranou E; Figueiredo CR
Front Immunol; 2023; 14():1152228. PubMed ID: 37077920
[TBL] [Abstract][Full Text] [Related]
3. Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy.
Wang H; Liu B; Wei J
Cancer Lett; 2021 Oct; 517():96-104. PubMed ID: 34129878
[TBL] [Abstract][Full Text] [Related]
4. Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
Haworth KB; Arnold MA; Pierson CR; Leddon JL; Kurmashev DK; Swain HM; Hutzen BJ; Roberts RD; Cripe TP
Pediatr Blood Cancer; 2016 Apr; 63(4):618-26. PubMed ID: 26575538
[TBL] [Abstract][Full Text] [Related]
5. β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system.
Ardeniz Ö; Unger S; Onay H; Ammann S; Keck C; Cianga C; Gerçeker B; Martin B; Fuchs I; Salzer U; İkincioğulları A; Güloğlu D; Dereli T; Thimme R; Ehl S; Schwarz K; Schmitt-Graeff A; Cianga P; Fisch P; Warnatz K
J Allergy Clin Immunol; 2015 Aug; 136(2):392-401. PubMed ID: 25702838
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
7. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.
Del Campo AB; Carretero J; Muñoz JA; Zinchenko S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F; Aptsiauri N
Cancer Gene Ther; 2014 Aug; 21(8):317-32. PubMed ID: 24971583
[TBL] [Abstract][Full Text] [Related]
9. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
D'Urso CM; Wang ZG; Cao Y; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jan; 87(1):284-92. PubMed ID: 1898655
[TBL] [Abstract][Full Text] [Related]
10. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
Restifo NP; Marincola FM; Kawakami Y; Taubenberger J; Yannelli JR; Rosenberg SA
J Natl Cancer Inst; 1996 Jan; 88(2):100-8. PubMed ID: 8537970
[TBL] [Abstract][Full Text] [Related]
11. Nonstructural Protein 4 of Porcine Reproductive and Respiratory Syndrome Virus Modulates Cell Surface Swine Leukocyte Antigen Class I Expression by Downregulating β2-Microglobulin Transcription.
Qi P; Liu K; Wei J; Li Y; Li B; Shao D; Wu Z; Shi Y; Tong G; Qiu Y; Ma Z
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003480
[TBL] [Abstract][Full Text] [Related]
12. Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin.
Zhang D; Liu K; Lu D; Wang P; Zhang Q; Liu P; Zhao Y; Chai Y; Lyu J; Qi J; Liu WJ
J Vis Exp; 2021 Mar; (169):. PubMed ID: 33779591
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Immune Responses in B2M-Deficient Cancers.
Torrejon DY; Galvez M; Abril-Rodriguez G; Campbell KM; Medina E; Vega-Crespo A; Kalbasi A; Comin-Anduix B; Ribas A
Cancer Immunol Res; 2023 Dec; 11(12):1642-1655. PubMed ID: 37801341
[TBL] [Abstract][Full Text] [Related]
14. beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
Hicklin DJ; Wang Z; Arienti F; Rivoltini L; Parmiani G; Ferrone S
J Clin Invest; 1998 Jun; 101(12):2720-9. PubMed ID: 9637706
[TBL] [Abstract][Full Text] [Related]
15. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
[TBL] [Abstract][Full Text] [Related]
16. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression.
Kingsbury DJ; Mear JP; Witte DP; Taurog JD; Roopenian DC; Colbert RA
Arthritis Rheum; 2000 Oct; 43(10):2290-6. PubMed ID: 11037889
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA class I molecules assembled with structural variants of human beta2-microglobulin.
Trymbulak WP; Zeff RA
Immunogenetics; 1997; 46(5):418-26. PubMed ID: 9271632
[TBL] [Abstract][Full Text] [Related]
18. MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.
Rodig SJ; Gusenleitner D; Jackson DG; Gjini E; Giobbie-Hurder A; Jin C; Chang H; Lovitch SB; Horak C; Weber JS; Weirather JL; Wolchok JD; Postow MA; Pavlick AC; Chesney J; Hodi FS
Sci Transl Med; 2018 Jul; 10(450):. PubMed ID: 30021886
[TBL] [Abstract][Full Text] [Related]
19. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.
Bernal M; Ruiz-Cabello F; Concha A; Paschen A; Garrido F
Cancer Immunol Immunother; 2012 Sep; 61(9):1359-71. PubMed ID: 22833104
[TBL] [Abstract][Full Text] [Related]
20. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
Zaretsky JM; Garcia-Diaz A; Shin DS; Escuin-Ordinas H; Hugo W; Hu-Lieskovan S; Torrejon DY; Abril-Rodriguez G; Sandoval S; Barthly L; Saco J; Homet Moreno B; Mezzadra R; Chmielowski B; Ruchalski K; Shintaku IP; Sanchez PJ; Puig-Saus C; Cherry G; Seja E; Kong X; Pang J; Berent-Maoz B; Comin-Anduix B; Graeber TG; Tumeh PC; Schumacher TN; Lo RS; Ribas A
N Engl J Med; 2016 Sep; 375(9):819-29. PubMed ID: 27433843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
